• Dosing Begins in Phase 3 Trial of Pfizer’s Gene Therapy for Duchenne
  • I Make Sure My Support System Is Strong
  • DMD Boys Experience Biological, Functional Gains in SRP-9001 Study
  • NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum
  • Why Freelancing Works for My Life With Duchenne
  • Pivotal Trial Begins for AMO-02 in Steinert Disease
  • Top 10 Muscular Dystrophy Stories of 2020
  • Edgewise Will Use $95M Funding to Advance EDG-5506 for BMD, DMD
  • It’s Time to Spread Some Holiday Cheer
  • Genethon Cleared to Launch French Trial Testing GNT0004 Gene Therapy for DMD
  • Lower-dose SRP-5051 Potentially More Effective Than Exondys 51, Phase 2 Trial Finds
  • Translarna Approved in Russia for DMD Patients 2 and Older